GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 137 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,265,000 | -70.1% | 24,752 | -69.1% | 0.16% | -59.1% |
| Q1 2019 | $4,234,000 | -29.8% | 80,000 | -45.6% | 0.39% | -43.2% |
| Q4 2018 | $6,034,000 | +53.3% | 147,000 | +47.0% | 0.68% | +47.2% |
| Q4 2017 | $3,935,000 | -0.2% | 100,000 | -21.3% | 0.46% | -17.9% |
| Q3 2017 | $3,943,000 | -3.9% | 127,000 | -15.3% | 0.56% | -19.2% |
| Q2 2017 | $4,103,000 | +127.2% | 150,000 | +20.0% | 0.70% | +52.5% |
| Q4 2016 | $1,806,000 | – | 125,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
| Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
| Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
| NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
| Grace Capital | 244,914 | $12,882,000 | 6.14% |
| Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
| Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
| ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
| STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |